SCHEMBL1807951

SCHEMBL1807951

COc1ccc(/C=C/c2cc3cc(OC)c(OC)cc3o2)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 8/20 0.66
MAPT P10636 3/20 0.58
ALDH1A1 P00352 2/20 0.58
HPGD P15428 2/20 0.58
KDM4E B2RXH2 2/20 0.58
TP53 P04637 1/20 0.57
CASP1 P29466 1/20 0.57
CASP7 P55210 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
HSD17B10 Q99714 1/20 0.57
TUBB4A P04350 3/20 0.57
TUBB P07437 3/20 0.57
TUBA3C P0DPH7 3/20 0.57
TUBA1B P68363 3/20 0.57
TUBA4A P68366 3/20 0.57
TUBB4B P68371 3/20 0.57
TUBB3 Q13509 3/20 0.57
TUBB2A Q13885 3/20 0.57
TUBB8 Q3ZCM7 3/20 0.57
TUBA3E Q6PEY2 3/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1807952 1.00 APP (0.66) APPMAPTALDH1A1HPGDKDM4E
SCHEMBL1804423 0.88 APP (0.83) APPMAPTALDH1A1HPGDKDM4E
SCHEMBL1804421 0.88 APP (0.83) APPMAPTALDH1A1HPGDKDM4E
SCHEMBL1512321 0.88 APP (0.59) APPMAPTALDH1A1HPGDKDM4E
SCHEMBL1512322 0.88 APP (0.59) APPMAPTALDH1A1HPGDKDM4E
SCHEMBL1806968 0.86 APP (0.59) APPMAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL1806967 0.86 APP (0.59) APPMAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL1805301 0.86 APP (0.84) APPMAPTALDH1A1HPGDKDM4E
SCHEMBL1805299 0.86 APP (0.84) APPMAPTALDH1A1HPGDKDM4E
SCHEMBL1806823 0.84 APP (0.75) APPMAPTALDH1A1HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110124888-A1 STYRYLBENZOFURAN DERIVATIVES AS INHIBITORS FOR BETA-AMYLOID FIBRIL FORMATION AND PREPARATION METHOD THEREOF KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2011-05-26 US claimed
US-20110124888-A1 STYRYLBENZOFURAN DERIVATIVES AS INHIBITORS FOR BETA-AMYLOID FIBRIL FORMATION AND PREPARATION METHOD THEREOF KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2011-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110124888-A1 STYRYLBENZOFURAN DERIVATIVES AS INHIBITORS FOR BETA-AMYLOID FIBRIL FORMATION AND PREPARATION METHOD THEREOF APP, BACE1, PSEN1 APP 1/4885MAPT 7/4885ALDH1A1 1198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.